JAM
KURA icon

Jupiter Asset Management’s Kura Oncology KURA Stock Holding History

Jupiter Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57,877
Closed -$832K – 479
2023
Q4 		$832K Hold
57,877
– – 0.01% 395
2023
Q3 		$528K Buy
57,877
+40,560
+234% +$412K 0.01% 429
2023
Q2 		$183K Buy
+17,317
New +$205K ﹤0.01% 489

Other funds holding KURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Jupiter Asset Management's KURA Position: Q1 2024 in Review

Jupiter Asset Management sold out of Kura Oncology (KURA) in Q1 2024, closing a stake of 57,877 shares — an estimated $832K sold.

Jupiter Asset Management first reported a position in KURA in Q2 2023 and held it in 3 quarters. The position peaked at $832K in Q4 2023. 165 funds tracked by Wall St. Rank hold KURA as of Q1 2024.

  • Jupiter Asset Management reported no remaining Kura Oncology position as of Q1 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 57,877 Kura Oncology shares in Q1 2024, an estimated $832K.
  • Jupiter Asset Management first reported a position in Kura Oncology in Q2 2023 and held it in 3 quarters.
  • Jupiter Asset Management's Kura Oncology position peaked at $832K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2024.

Based on Jupiter Asset Management's 13F filing for Q1 2024, filed 10 May 2024.